Cargando…

Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies

BACKGROUND: Glioblastoma (GBM) is the most malignant among gliomas with an inevitable lethal outcome. The elucidation of the physiology and regulation of this tumor is mandatory to unravel novel target and effective therapeutics. Emerging concepts show that the minor subset of glioblastoma stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Visioli, Alberto, Trivieri, Nadia, Mencarelli, Gandino, Giani, Fabrizio, Copetti, Massimiliano, Palumbo, Orazio, Pracella, Riccardo, Cariglia, Maria Grazia, Barile, Chiara, Mischitelli, Luigi, Soriano, Amata Amy, Palumbo, Pietro, Legnani, Federico, DiMeco, Francesco, Gorgoglione, Leonardo, Pesole, Graziano, Vescovi, Angelo L., Binda, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512479/ https://www.ncbi.nlm.nih.gov/pubmed/37735434 http://dx.doi.org/10.1186/s13046-023-02811-0

Ejemplares similares

Growth factor independence underpins a paroxysmal, aggressive Wnt5a(High)/EphA2(Low) phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy
por: Trivieri, Nadia, et al.
Publicado: (2022)

Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies
por: Visioli, Alberto, et al.
Publicado: (2019)

BRAF(V600E) mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies
por: Trivieri, Nadia, et al.
Publicado: (2020)

A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia
por: Colucci, Mattia, et al.
Publicado: (2023)

Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial
por: Bos, Eelke M., et al.
Publicado: (2023)

Current and Future Novel Treatments for Glioblastoma Multiforme
por: Tyler, Betty, et al.
Publicado: (2014)

Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome
por: Binder, Zev A., et al.
Publicado: (2013)

Extracellular vesicles: The key for precision medicine in glioblastoma
por: Del Bene, Massimiliano, et al.
Publicado: (2021)

Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness
por: Richichi, Cristina, et al.
Publicado: (2016)

Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response
por: Pizzocri, Marco, et al.
Publicado: (2021)

GFAP serves as a structural element of tunneling nanotubes between glioblastoma cells and could play a role in the intercellular transfer of mitochondria
por: Simone, L., et al.
Publicado: (2023)

Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression
por: Angelucci, Cristiana, et al.
Publicado: (2018)

Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
por: Scicchitano, Bianca Maria, et al.
Publicado: (2018)

Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms
por: Mazzarelli, Antonio, et al.
Publicado: (2022)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
por: Kalkan, Rasime
Publicado: (2015)

Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2017)

Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue
por: Wallenborn, Marco, et al.
Publicado: (2020)

Cancer stem cells in glioblastoma
por: Lathia, Justin D., et al.
Publicado: (2015)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

In Silico Mathematical Modelling for Glioblastoma: A Critical Review and a Patient-Specific Case
por: Falco, Jacopo, et al.
Publicado: (2021)

High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer
por: Trivieri, Nadia, et al.
Publicado: (2020)

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2020)

PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells
por: Seifert, Carolin, et al.
Publicado: (2021)

Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells
por: D'Alessio, Alessio, et al.
Publicado: (2016)

Cancer Stem Cells in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017)

The Role of SVZ Stem Cells in Glioblastoma
por: Altmann, Christine, et al.
Publicado: (2019)

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015)

Glioblastoma Stem Cells: A Neuropathologist's View
por: McLendon, Roger E., et al.
Publicado: (2011)

Cancer stem cell contribution to glioblastoma invasiveness
por: Ortensi, Barbara, et al.
Publicado: (2013)

Targeting Aggressive Cancer Stem Cells in Glioblastoma
por: Seymour, Tracy, et al.
Publicado: (2015)

Emerging targets for glioblastoma stem cell therapy
por: Safa, Ahmad R., et al.
Publicado: (2016)

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

EGFR Amplification and Glioblastoma Stem-Like Cells
por: Liffers, Katrin, et al.
Publicado: (2015)

Glioblastoma Stem Cells and Comparison of Isolation Methods
por: Dundar, Tolga Turan, et al.
Publicado: (2019)

Repurposing Clemastine to Target Glioblastoma Cell Stemness
por: Sun, Michael A., et al.
Publicado: (2023)

Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells
por: Park, Min Gi, et al.
Publicado: (2020)

Ex Vivo Fluorescein-Assisted Confocal Laser Endomicroscopy (CONVIVO® System) in Patients With Glioblastoma: Results From a Prospective Study
por: Acerbi, Francesco, et al.
Publicado: (2020)

Hypoxia Enhances Stemness of Cancer Stem Cells in Glioblastoma: An In Vitro Study
por: Li, Pengcheng, et al.
Publicado: (2013)

MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells
por: Deng, Yifan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7vl9k86bml4jr6c81f40luv9e7